TipRanks
Innate Pharma (IPHA)
NASDAQ:IPHA
Want to see IPHA full AI Analyst Report?

Compare Innate Pharma (IPHA) vs. Competitors

149 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma
$2.27
$202.72M
-3.10
-2.06%
3 Buy
0 Hold
0 Sell
Strong Buy
SELLAS Life Sciences Group
$14.09
$2.32B
-54.38
613.66%
2 Buy
0 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$3.01
$49.67M
-0.89
-83.52%
1 Buy
1 Hold
0 Sell
Moderate Buy
Vor Biopharma
$24.01
$1.27B
-0.07
-29.61%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHA
Innate Pharma
1.90
0.07
3.83%
SLS
SELLAS Life Sciences Group
11.49
9.77
568.02%
SGMO
GNFT
ELTX
Elicio Therapeutics
1.89
-9.25
-83.03%
VOR
Vor Biopharma
21.40
-6.54
-23.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts